Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It's administered with a tiny needle that punctures ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

New Delhi: Dr Reddy's Laboratories on Saturday said it has launched its generic version of Semaglutide injection used in treatment of type 2 diabetes in Canada. The company is among the first firms to ...

Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular as a weight loss treatment. While the drug—commonly known by brand names ...

The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – became the first GLP-1 available to buy as a daily pill. Wegovy was ...

Studies show tirzepatide leads to significantly more weight loss on average compared to semaglutide. Tirzepatide and semaglutide are both FDA-approved weekly injections for weight management and type ...